Brad Wasserman

601 total citations
10 papers, 418 citations indexed

About

Brad Wasserman is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brad Wasserman has authored 10 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brad Wasserman's work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Cells and Metastasis (3 papers) and Cardiac pacing and defibrillation studies (2 papers). Brad Wasserman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cancer Cells and Metastasis (3 papers) and Cardiac pacing and defibrillation studies (2 papers). Brad Wasserman collaborates with scholars based in United States, Greece and United Kingdom. Brad Wasserman's co-authors include David L. Rimm, Vasiliki Pelekanou, Daniel Carvajal‐Hausdorf, Nikita Mani, Kurt A. Schalper, Mehmet Altan, Gang Han, Jamaal Rehman, Joseph McLaughlin and Lajos Pusztai and has published in prestigious journals such as Journal of Clinical Oncology, Nature Reviews Cardiology and Molecular Cancer Therapeutics.

In The Last Decade

Brad Wasserman

10 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brad Wasserman United States 7 347 144 104 89 39 10 418
Zhuxing Chen China 8 231 0.7× 145 1.0× 108 1.0× 47 0.5× 46 1.2× 18 363
Danilo Galizia Italy 10 179 0.5× 108 0.8× 35 0.3× 68 0.8× 26 0.7× 32 285
Lyudmila Zhukova Russia 7 201 0.6× 122 0.8× 38 0.4× 70 0.8× 37 0.9× 89 287
Yuji Hirami Japan 10 222 0.6× 162 1.1× 145 1.4× 74 0.8× 32 0.8× 21 405
Emanuela Romagnoli Italy 7 188 0.5× 85 0.6× 105 1.0× 56 0.6× 18 0.5× 16 279
Alessandro Dal Maso Italy 10 286 0.8× 200 1.4× 48 0.5× 99 1.1× 27 0.7× 25 388
Masatoshi Kanayama Japan 11 245 0.7× 158 1.1× 69 0.7× 29 0.3× 48 1.2× 49 351
Yueyun Chen China 9 170 0.5× 108 0.8× 62 0.6× 57 0.6× 64 1.6× 27 301
Yoshiro Nakahara Japan 12 282 0.8× 255 1.8× 44 0.4× 54 0.6× 23 0.6× 42 414
Virginia Palomar Coloma France 4 421 1.2× 190 1.3× 118 1.1× 48 0.5× 65 1.7× 5 481

Countries citing papers authored by Brad Wasserman

Since Specialization
Citations

This map shows the geographic impact of Brad Wasserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Wasserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Wasserman more than expected).

Fields of papers citing papers by Brad Wasserman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad Wasserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Wasserman. The network helps show where Brad Wasserman may publish in the future.

Co-authorship network of co-authors of Brad Wasserman

This figure shows the co-authorship network connecting the top 25 collaborators of Brad Wasserman. A scholar is included among the top collaborators of Brad Wasserman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad Wasserman. Brad Wasserman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Toki, Maria, Nikita Mani, James W. Smithy, et al.. (2018). Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations. Journal of Thoracic Oncology. 13(12). 1884–1896. 82 indexed citations
2.
Yousef, Zaheer, Aimé Bonny, Kevin J. Weatherwax, et al.. (2018). Using reconditioned pacemakers to treat bradycardia in Africa. Nature Reviews Cardiology. 15(12). 725–726. 8 indexed citations
3.
Pelekanou, Vasiliki, William E. Barlow, Zeina Nahleh, et al.. (2018). Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial. Molecular Cancer Therapeutics. 17(6). 1324–1331. 64 indexed citations
4.
Wasserman, Brad, Daniel Carvajal‐Hausdorf, Wendy Wong, et al.. (2017). High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence. Laboratory Investigation. 97(12). 1521–1526. 20 indexed citations
5.
Pelekanou, Vasiliki, Daniel Carvajal‐Hausdorf, Mehmet Altan, et al.. (2017). Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance. Breast Cancer Research. 19(1). 109–109. 86 indexed citations
6.
Toki, Maria, Nikita Mani, James W. Smithy, et al.. (2017). Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.. Journal of Clinical Oncology. 35(15_suppl). 9076–9076. 3 indexed citations
7.
Pelekanou, Vasiliki, William E. Barlow, Brad Wasserman, et al.. (2017). Effects of neoadjuvant chemotherapy (NAC) on tumor infiltrating lymphocytes (TIL) and PD-L1 expression in the SWOG S0800 clinical trial.. Journal of Clinical Oncology. 35(15_suppl). 519–519. 6 indexed citations
8.
Rehman, Jamaal, Gang Han, Daniel Carvajal‐Hausdorf, et al.. (2016). Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer. Modern Pathology. 30(3). 340–349. 124 indexed citations
9.
Gaule, Patricia, Jamaal Rehman, James W. Smithy, et al.. (2016). Measurement of spatial and antibody-based PD-L1 heterogeneity in non-small cell lung cancer.. Journal of Clinical Oncology. 34(15_suppl). 9040–9040. 1 indexed citations
10.
Baman, Timir S., Thomas Crawford, Pascal Meier, et al.. (2011). Feasibility of postmortem device acquisition for potential reuse in underserved nations. Heart Rhythm. 9(2). 211–214. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuxing Chen Breakdown of academic impact, for papers by Danilo Galizia Breakdown of academic impact, for papers by Lyudmila Zhukova Breakdown of academic impact, for papers by Yuji Hirami Breakdown of academic impact, for papers by Emanuela Romagnoli Breakdown of academic impact, for papers by Alessandro Dal Maso Breakdown of academic impact, for papers by Masatoshi Kanayama Breakdown of academic impact, for papers by Yueyun Chen Breakdown of academic impact, for papers by Yoshiro Nakahara Breakdown of academic impact, for papers by Virginia Palomar Coloma
Rankless by CCL
2026